Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma

European Journal of Immunology

Volumn 41, Issue 2, 2011, Pages 437-449

  Skliris, Antonis ^a   Happonen, Kaisa E ^b   Terpos, Evangelos ^c   Labropoulou, Vassiliki ^d   Børset, Magne ^e   Heinegard, Dick ^f   Blom, Anna M ^b   Theocharis, Achilleas D ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f LUND UNIVERSITY   (Sweden)

Author keywords

Complement; Multiple myeloma; Serglycin

Indexed keywords

CALCIUM; CHONDROITIN SULFATE; COMPLEMENT COMPONENT C1Q; GLYCOSAMINOGLYCAN; LECTIN; MANNOSE BINDING LECTIN; PROTEOGLYCAN; SERGLYCIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING SITE; CELL PROTECTION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MALE; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 78851470656     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040429     Document Type: Article

References (37)

1. Stevens, R. L., Otsu, K. and Austen, K. F., Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell. J. Biol. Chem. 1985. 260: 14194-14200.
2. Kolset, S. O. and Tveit, H., Serglycin - structure and biology. Cell. Mol. Life Sci. 2008. 65: 1073-1085.
3. Kolset, S. O., Prydz, K. and Pejler, G., Intracellular proteoglycans. Biochem. J. 2004. 379: 217-227.
4. Enerback, L., Kolset, S. O., Kusche, M., Hjerpe, A. and Lindahl, U., Glycosaminoglycans in rat mucosal mast cells. Biochem. J. 1985. 227: 661-668.
5. Uhlin-Hansen, L., Eskeland, T. and Kolset, S. O., Modulation of the expression of chondroitin sulfate proteoglycan in stimulated human monocytes. J. Biol. Chem. 1989. 264: 14916-14922.
6. Zernichow, L., Abrink, M., Hallgren, J., Grujic, M., Pejler, G. and Kolset, S. O., Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide. J. Biol. Chem. 2006. 281: 26792-26801.
7. Abrink, M., Grujic, M. and Pejler, G., Serglycin is essential for maturation of mast cell secretory granule. J. Biol. Chem. 2004. 279: 40897-40905.
8. Grujic, M., Braga, T., Lukinius, A., Eloranta, M. L., Knight, S. D., Pejler, G. and Abrink, M., Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J. Biol. Chem. 2005. 280: 33411-33418.
9. Raja, S. M., Metkar, S. S., Honing, S., Wang, B., Russin, W. A., Pipalia, N. H., Menaa, C. et al., A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cells. J. Biol. Chem. 2005. 280: 20752-20761.
10. Theocharis, A. D., Seidel, C., Borset, M., Dobra, K., Baykov, V., Labropoulou, V., Kanakis, I. et al., Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J. Biol. Chem. 2006. 281: 35116-35128.
11. Pratt, G., Goodyear, O. and Moss, P., Immunodeficiency and immunotherapy in multiple myeloma. Br. J. Haematol. 2007. 138: 563-579.
12. Kraut, E. H. and Sagone, A. L., Jr., Alternative pathway of complement in multiple myeloma. Am. J. Hematol. 1981. 11: 335-345.
13. Zurlo, J. J., Schechter, G. P. and Fries, L. F., Complement abnormalities in multiple myeloma. Am. J. Med. 1989. 87: 411-420.
14. Weiner, S. M., Prasauskas, V., Lebrecht, D., Weber, S., Peter, H. H. and Vaith, P., Occurrence of C-reactive protein in cryoglobulins. Clin. Exp. Immunol. 2001. 125: 316-322.
15. Tedeschi, A., Barate, C., Minola, E. and Morra, E., Cryoglobulinemia. Blood Rev. 2007. 21: 183-200.
16. Trouw, L. A., Blom, A. M. and Gasque, P., Role of complement and complement regulators in the removal of apoptotic cells. Mol. Immunol. 2008. 45: 1199-1207.
17. Walport, M. J., Complement. First of two parts. N. Engl. J. Med. 2001. 344: 1058-1066.
18. Walport, M. J., Complement. Second of two parts. N. Engl. J. Med. 2001. 344: 1140-1144.
19. Wolbink, G. J., Brouwer, M. C., Buysmann, S., ten Berge, I. J. and Hack, C. E., CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J. Immunol. 1996. 157: 473-479.
20. Sjöberg, A., Önnerfjord, P., Mörgelin, M., Heinegård, D. and Blom, A. M., The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J. Biol. Chem. 2005. 280: 32301-32308.
21. Sjöberg, A. P., Manderson, G. A., Mörgelin, M., Day, A. J., Heinegård, D. and Blom, A. M., Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol. Immunol. 2009. 46: 830-839.
22. Sjöberg, A. P., Trouw, L. A. and Blom, A. M., Complement activation and inhibition: a delicate balance. Trends Immunol. 2009. 30: 83-90.
23. Groeneveld, T. W., Oroszlan, M., Owens, R. T., Faber-Krol, M. C., Bakker, A. C., Arlaud, G. J., McQuillan, D. J. et al., Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J. Immunol. 2005. 175: 4715-4723.
24. Kirschfink, M., Blase, L., Engelmann, S. and Schwartz-Albiez, R., Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. J. Immunol. 1997. 158: 1324-1331.
25. Garantziotis, S., Hollingsworth, J. W., Ghanayem, R. B., Timberlake, S., Zhuo, L., Kimata, K. and Schwartz, D. A., Inter-alpha-trypsin inhibitor attenuates complement activation and complement-induced lung injury. J. Immunol. 2007. 179: 4187-4192.
26. Chakraverty, R., Peggs, K., Chopra, R., Milligan, D. W., Kottaridis, P. D., Verfuerth, S., Geary, J. et al., Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 2002. 99: 1071-1078.
27. Kroger, N., Schwerdtfeger, R., Kiehl, M., Sayer, H. G., Renges, H., Zabelina, T., Fehse, B. et al., Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. Blood 2002. 100: 755-760.
28. Ayuk, F. A., Fang, L., Fehse, B., Zander, A. R. and Kroger, N., Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells. Exp. Hematol. 2005. 33: 1531-1536.
29. Heinegård D., Franzén, A., Lorenzo, P., Non-collagenous Glycoproteins in the Extracellular Matrix, with Particular Reference to Cartilage and Bone. Wiley, New York 2002.
30. Heinegård, D., Larsson, T., Sommarin, Y., Franzen, A., Paulsson, M. and Hedbom, E., Two novel matrix proteins isolated from articular cartilage show wide distributions among connective tissues. J. Biol. Chem. 1986. 261: 13866-13872.
31. Tenner, A. J., Lesavre, P. H. and Cooper, N. R., Purification and radiolabeling of human C1q. J. Immunol. 1981. 127: 648-653.
32. Garcia de Frutos, P., Härdig, Y. and Dahlbäck, B., Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 1995. 270: 26950-26955.
33. Blom, A. M., Kask, L. and Dahlbäck, B., CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. Mol. Immunol. 2003. 39: 547-556.
34. Paques, E. P., Huber, R., Priess, H. and Wright, J. K., Isolation of the globular region of the subcomponent q of the C1 component of complement. Hoppe Seylers Z. Physiol. Chem. 1979. 360: 177-183.
35. Reid, K. B. and Porter, R. R., Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem. J. 1976. 155: 19-23.
36. Theocharis, A. D., Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim. Biophys. Acta 2002. 1588: 165-172.
37. Heinegård, D., Björne-Persson, A., Coster, L., Franzen, A., Gardell, S., Malmström, A., Paulsson, M. et al., The core proteins of large and small interstitial proteoglycans from various connective tissues form distinct subgroups. Biochem. J. 1985. 230: 181-194.